FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jacobus Pfisterer

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Geographic Areas

Germany

Physiology

Drug Resistance, Neoplasm

Co-author Network

Publications

TOP 3
Andreas du Bois; Nina Ewald-Riegler; Tanja Fehm; Dirk Forner; Christina Fotopoulou; Lars Hanker; Annette Hasenburg; Klaus Baumann; Alexander Burges; Ulrich Canzler; Nikolaus de Gregorio; Martin Hellriegel; Peter Hillemanns; Felix Hilpert; Mignon-Denise Keyver-Paik; Friedrich Kommoss; Stefan Kommoss; Sven Mahner; Werner Meier; Karsten Münstedt; Jacobus Pfisterer; Alexander Reuss; Barbara Richter; Barbara Schmalfeldt; Willibald Schröder; Hans-Georg Strauss; Pauline Wimberger; Kerstin Wollschlaeger; Steffen Hauptmann
Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group.
Sven Mahner; Jacobus Pfisterer
Towards individualised treatment in ovarian cancer.
Sven Mahner; Jacobus Pfisterer; Eric Pujade-Lauraine; I Ray-Coquard; A Reuss; A Staehle; K Wegscheider; C Eulenburg; Philipp Harter; Andreas du Bois
Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: analysis of prospective randomised phase III trials.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jacobus Pfisterer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Andreas du Bois; Nina Ewald-Riegler; Tanja Fehm; Dirk Forner; Christina Fotopoulou; Lars Hanker; Annette Hasenburg; Klaus Baumann; Alexander Burges; Ulrich Canzler; Nikolaus de Gregorio; Martin Hellriegel; Peter Hillemanns; Felix Hilpert; Mignon-Denise Keyver-Paik; Friedrich Kommoss; Stefan Kommoss; Sven Mahner; Werner Meier; Karsten Münstedt; Jacobus Pfisterer; Alexander Reuss; Barbara Richter; Barbara Schmalfeldt; Willibald Schröder; Hans-Georg Strauss; Pauline Wimberger; Kerstin Wollschlaeger; Steffen Hauptmann
Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group.
European journal of cancer (Oxford, England : 1990) 2013;49(8):1905-14.
2013: Sven Mahner; Jacobus Pfisterer
Towards individualised treatment in ovarian cancer.
The lancet oncology 2013;14(2):101-2.
2013: Sven Mahner; Jacobus Pfisterer; Eric Pujade-Lauraine; I Ray-Coquard; A Reuss; A Staehle; K Wegscheider; C Eulenburg; Philipp Harter; Andreas du Bois
Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: analysis of prospective randomised phase III trials.
European journal of cancer (Oxford, England : 1990) 2013;49(1):142-9.
2011: K Baumann; N Burchardi; Andreas du Bois; Jens Huober; Christian Kurzeder; Sibylle Loibl; H J Lück; Jacobus Pfisterer; Barbara Schmalfeldt; Jalid Sehouli; I Vergote; Pauline Wimberger; U Wagner
Intraperitoneal treatment with the trifunctional bispecific antibody Catumaxomab in patients with platinum-resistant epithelial ovarian cancer: a phase IIa study of the AGO Study Group.
Gynecologic oncology 2011;123(1):27-32.
2011: Elfriede Greimel; Felix Hilpert; Jacobus Pfisterer; Eric Pujade-Lauraine; Vesna Bjelic-Radisic; Fedor Daghofer; Andreas du Bois
Toxicity and quality of life outcomes in ovarian cancer patients participating in randomized controlled trials.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2011;19(9):1421-7.
2010: Andreas du Bois; Jørn Herrstedt; Anne-Claire Hardy-Bessard; Hans-Helge Müller; Philipp Harter; Gunnar Kristensen; Florence Joly; Jens Huober; Elisabeth Avall-Lundqvist; Béatrice Weber; Christian Kurzeder; Svetislav Jelic; Eric Pujade-Lauraine; Alexander Burges; Jacobus Pfisterer; Martina Gropp; Anne Staehle; Pauline Wimberger; Christian Jackisch; Jalid Sehouli
Phase III trial of carboplatin plus paclitaxel with or without gemcitabine in first-line treatment of epithelial ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(27):4162-9.
2010: Pauline Wimberger; Michael Wehling; Nils Lehmann; Rainer Kimmig; Barbara Schmalfeldt; Alexander Burges; Philipp Harter; Jacobus Pfisterer; Andreas du Bois
Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease: an exploratory analysis of the AGO-OVAR (Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group).
Annals of surgical oncology 2010;17(6):1642-8.
2010: G Oskay-Ozcelik; R Chekerov; Harald Sommer; E Keil; J Einenkel; Jacobus Pfisterer; C Lorenz-Schlüter; Werner Lichtenegger; Oumar Camara; Jalid Sehouli
Sequential chemotherapy with carboplatin followed by weekly paclitaxel in advanced ovarian cancer: results of a multicenter phase II study of the northeastern German society of gynecological oncology.
Gynecologic oncology 2010;116(3):317-22.
2010: Andreas du Bois; Jens Huober; P Stopfer; Jacobus Pfisterer; Pauline Wimberger; Sibylle Loibl; V L Reichardt; Philipp Harter
A phase I open-label dose-escalation study of oral BIBF 1120 combined with standard paclitaxel and carboplatin in patients with advanced gynecological malignancies.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(2):370-5.
2010: Philipp Harter; Felix Hilpert; Sven Mahner; Florian Heitz; Jacobus Pfisterer; Andreas du Bois
Systemic therapy in recurrent ovarian cancer: current treatment options and new drugs.
Expert review of anticancer therapy 2010;10(1):81-8.
2009: Philipp Harter; Felix Hilpert; Sven Mahner; Stefan Kommoss; Florian Heitz; Jacobus Pfisterer; Andreas du Bois
Prognostic factors for complete debulking in first- and second-line ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19 Suppl 2():S14-7.
2009: Andreas du Bois; Alexander Reuss; Eric Pujade-Lauraine; Philipp Harter; ISABELLE RAY COQUARD; Jacobus Pfisterer
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO).
Cancer 2009;115(6):1234-44.
2009: Stefan Kommoss; Dietmar Schmidt; Friedrich Kommoss; Juergen Hedderich; Philipp Harter; Jacobus Pfisterer; Andreas du Bois
Histological grading in a large series of advanced stage ovarian carcinomas by three widely used grading systems: consistent lack of prognostic significance. A translational research subprotocol of a prospective randomized phase III study (AGO-OVAR 3 protocol).
Virchows Archiv : an international journal of pathology 2009;454(3):249-56.
2009: Andreas du Bois; Justine Rochon; Jacobus Pfisterer; William J Hoskins
Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: a systematic review.
Gynecologic oncology 2009;112(2):422-36.
2009: Jacobus Pfisterer; Andreas du Bois; Eva-Katrin Bentz; Friedrich Kommoss; Philipp Harter; Jens Huober; Barbara Schmalfeldt; Nicole Burchardi; Norbert Arnold; Felix Hilpert
Prognostic value of human epidermal growth factor receptor 2 (Her-2)/neu in patients with advanced ovarian cancer treated with platinum/paclitaxel as first-line chemotherapy: a retrospective evaluation of the AGO-OVAR 3 Trial by the AGO OVAR Germany.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19(1):109-15.
2008: Friedrich Kommoss; Stefan Kommoss; Dietmar Schmidt; Andreas du Bois; Jacobus Pfisterer
[Central pathology review. Inclusion criterion for clinical studies of ovarian carcinomas?].
Der Pathologe 2008;29 Suppl 2():157-9.
2008: Christina Fotopoulou; Andreas duBois; Alexandros N Karavas; Ralf Trappe; Behnaz Aminossadati; Barbara Schmalfeldt; Jacobus Pfisterer; Jalid Sehouli
Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(16):2683-9.
2008: Nicolas Wentzensen; Andreas du Bois; Stefan Kommoss; Jacobus Pfisterer; Magnus von Knebel Doeberitz; Dietmar Schmidt; Friedrich Kommoss
No metastatic cervical adenocarcinomas in a series of p16INK4a-positive mucinous or endometrioid advanced ovarian carcinomas: an analysis of the AGO Ovarian Cancer Study Group.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2008;27(1):18-23.
2007: Jacobus Pfisterer; Philipp Harter; Felix Hilpert; Andreas du Bois
[Peritoneal carcinomatosis in ovarian cancer. Methods and treatment results].
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 2007;78(12):1111-6.
2007: Andreas du Bois; Jacobus Pfisterer; N Burchardi; Sibylle Loibl; Jens Huober; Pauline Wimberger; Alexander Burges; Anne Stähle; Christian Jackisch; H Kölbl
Combination therapy with pegylated liposomal doxorubicin and carboplatin in gynecologic malignancies: a prospective phase II study of the Arbeitsgemeinschaft Gynäekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and Kommission Uterus (AGO-K-Ut).
Gynecologic oncology 2007;107(3):518-25.
2007: Alexander Burges; Pauline Wimberger; Carolin Kümper; Vera Gorbounova; Harald Sommer; Barbara Schmalfeldt; Jacobus Pfisterer; Michail R Lichinitser; Anatoliy Makhson; Vladimir Moiseyenko; Angelika Lahr; Elisabeth Schulze; Michael Jäger; Michael A Ströhlein; Markus M Heiss; Thomas Gottwald; Horst Lindhofer; Rainer Kimmig
Effective relief of malignant ascites in patients with advanced ovarian cancer by a trifunctional anti-EpCAM x anti-CD3 antibody: a phase I/II study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(13):3899-905.
2007: Uwe Wagner; Andreas du Bois; Jacobus Pfisterer; Jens Huober; Sibylle Loibl; Hans-Joachim Lück; Jalid Sehouli; Martina Gropp; Anne Stähle; Barbara Schmalfeldt; Werner Meier; Christian Jackisch
Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum-taxane based therapy--a phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6).
Gynecologic oncology 2007;105(1):132-7.
2007: Felix Hilpert; Andreas du Bois; Elfriede Greimel; J Hedderich; G Krause; L Venhoff; Sibylle Loibl; Jacobus Pfisterer
Feasibility, toxicity and quality of life of first-line chemotherapy with platinum/paclitaxel in elderly patients aged >or=70 years with advanced ovarian cancer--a study by the AGO OVAR Germany.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(2):282-7.
2007: Stefan Kommoss; Andreas du Bois; Ruediger Ridder; Marcus J Trunk; D Schmidt; Jacobus Pfisterer; Friedrich Kommoss
Independent prognostic significance of cell cycle regulator proteins p16(INK4a) and pRb in advanced-stage ovarian carcinoma including optimally debulked patients: a translational research subprotocol of a randomised study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
British journal of cancer 2007;96(2):306-13.
2007: Ivo Meinhold-Heerlein; Dirk Bauerschlag; Yingyao Zhou; Lisa M Sapinoso; Keith Ching; Henry F Frierson; Karen Bräutigam; Jalid Sehouli; Elmar Stickeler; Dominique Könsgen; Felix Hilpert; Constantin S von Kaisenberg; Jacobus Pfisterer; Thomas Bauknecht; Walter Jonat; Norbert Arnold; Garret M Hampton
An integrated clinical-genomics approach identifies a candidate multi-analyte blood test for serous ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(2 Pt 1):458-66.
2006: Philipp Harter; Andreas du Bois; Maik Hahmann; Annette Hasenburg; Alexander Burges; Sibylle Loibl; Martina Gropp; Jens Huober; Daniel Fink; Willibald Schröder; Karsten Muenstedt; Barbara Schmalfeldt; Guenter Emons; Jacobus Pfisterer; Kerstin Wollschlaeger; Hans-Gerd Meerpohl; Georg-Peter Breitbach; Berno Tanner; Jalid Sehouli
Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial.
Annals of surgical oncology 2006;13(12):1702-10.
2006: Jacobus Pfisterer; Marie Plante; Ignace Vergote; Andreas du Bois; Hal Hirte; Angel J Lacave; Uwe Wagner; Anne Stähle; Gavin Stuart; Rainer Kimmig; Sigrid Olbricht; Tien Le; Janusz Emerich; Walther Kuhn; James Bentley; Christian Jackisch; Hans-Joachim Lück; Justine Rochon; Annamaria Hayden Zimmermann; Elizabeth Eisenhauer
Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(29):4699-707.
2006: Jacobus Pfisterer; Andreas du Bois; Jalid Sehouli; Sibylle Loibl; S Reinartz; Alexander Reuss; U Canzler; A Belau; Christian Jackisch; Rainer Kimmig; Kerstin Wollschlaeger; Volker Heilmann; Felix Hilpert
The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVAR.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(10):1568-77.
2006: Robert F Ozols; Michael A Bookman; Andreas du Bois; Jacobus Pfisterer; Alexander Reuss; Robert C Young
Intraperitoneal cisplatin therapy in ovarian cancer: comparison with standard intravenous carboplatin and paclitaxel.
Gynecologic oncology 2006;103(1):1-6.
2006: Stefan Kommoss; Andreas du Bois; Dietmar Schmidt; R Parwaresch; Jacobus Pfisterer; Friedrich Kommoss
Chemotherapy may be more effective in highly proliferative ovarian carcinomas--a translational research subprotocol of a prospective randomized phase III study (AGO-OVAR 3 protocol).
Gynecologic oncology 2006;103(1):67-71.
2006: Andreas du Bois; Barbara Schmalfeldt; Werner Meier; Jalid Sehouli; Jacobus Pfisterer
Ovarian cancer--can intraperitoneal therapy be regarded as new standard in Germany?
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16(5):1756-60.
2006: Jacobus Pfisterer; Béatrice Weber; Alexander Reuss; Rainer Kimmig; Andreas du Bois; Uwe Wagner; Hugues Bourgeois; Werner Meier; Serban Costa; Jens-Uwe Blohmer; Alain Lortholary; Sigrid Olbricht; Anne Stähle; Christian Jackisch; Anne-Claire Hardy-Bessard; Volker Möbus; Jens Quaas; Barbara Richter; Willibald Schröder; Jean-François Geay; Hans-Joachim Lück; Walther Kuhn; Harald Meden; Ulrike Nitz; Eric Pujade-Lauraine
Randomized phase III trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer: a gynecologic cancer intergroup trial of the AGO-OVAR and GINECO.
Journal of the National Cancer Institute 2006;98(15):1036-45.
2006: Andreas du Bois; Barbara Schmalfeldt; W Meier; Jalid Sehouli; Jacobus Pfisterer
[Ovarian cancer -- can peritoneal therapy be regarded as new standard?].
Zentralblatt für Gynäkologie 2006;128(4):202-6.
2006: Jacobus Pfisterer; Jonathan A Ledermann
Management of platinum-sensitive recurrent ovarian cancer.
Seminars in oncology 2006;33(2 Suppl 6):S12-6.
2006: Andreas du Bois; Beatrice Weber; Justine Rochon; Werner Meier; Alain Goupil; Sigrid Olbricht; Jean-Claude Barats; Walther Kuhn; Hubert Orfeuvre; Uwe Wagner; Barbara Richter; Hans-Joachim Lueck; Jacobus Pfisterer; Serban Costa; Willibald Schroeder; Rainer Kimmig; Eric Pujade-Lauraine
Addition of epirubicin as a third drug to carboplatin-paclitaxel in first-line treatment of advanced ovarian cancer: a prospectively randomized gynecologic cancer intergroup trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group and the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(7):1127-35.
2006: Barbara Schmalfeldt; Andreas du Bois; Alexander Burges; G Emons; D Fink; Martina Gropp; Annette Hasenburg; W Jäger; Rainer Kimmig; Marion Kiechle; Friedrich Kommoss; R Kreienberg; W Kuhn; Hans-Joachim Lück; Werner Meier; K Münstedt; O Ortmann; Jacobus Pfisterer; B Richter; Ingo B Runnebaum; W Schröder; Jalid Sehouli; B Tanner; Uwe Wagner; J Weis
[Diagnosis and treatment of malignant ovarian tumors 2005: recommendations of the Kommission Ovar of the AGO].
Zentralblatt für Gynäkologie 2006;128(1):11-7.
2006: Elfriede Greimel; Vesna Bjelic-Radisic; Jacobus Pfisterer; Felix Hilpert; Fedor Daghofer; Andreas du Bois
Randomized study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group comparing quality of life in patients with ovarian cancer treated with cisplatin/paclitaxel versus carboplatin/paclitaxel.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(4):579-86.
2006: Andreas du Bois; Alexander Burges; Werner Meier; Jacobus Pfisterer; Barbara Schmalfeldt; Barbara Richter; Christian Jackisch; A Staehle; Rainer Kimmig; G Elser
Pegylated liposomal doxorubicin and carboplatin in advanced gynecologic tumors: a prospective phase I/II study of the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(1):93-6.
2005: Jacobus Pfisterer; Philipp Harter; U Canzler; Barbara Richter; Christian Jackisch; M Hahmann; Annette Hasenburg; Alexander Burges; Sibylle Loibl; Martina Gropp; Jens Huober; D Fink; Andreas du Bois
The role of surgery in recurrent ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2005;15 Suppl 3():195-8.
2005: Philipp Harter; Andreas du Bois; C Schade-Brittinger; Alexander Burges; Kerstin Wollschlaeger; Martina Gropp; Barbara Schmalfeldt; Jens Huober; A Staehle; Jacobus Pfisterer
Non-enrolment of ovarian cancer patients in clinical trials: reasons and background.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(11):1801-5.
2005: Jacobus Pfisterer; Andreas du Bois
[Pharmacotherapy in ovarian carcinoma].
MMW Fortschritte der Medizin 2005;147(43):34-6.
2005: Andreas du Bois; Jacobus Pfisterer
Future options for first-line therapy of advanced ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2005;15 Suppl 1():42-50.
2005: Jacobus Pfisterer; I Vergote; Andreas du Bois; Elizabeth Eisenhauer
Combination therapy with gemcitabine and carboplatin in recurrent ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2005;15 Suppl 1():36-41.
2005: Friedrich Kommoss; Stefan Kommoss; Dietmar Schmidt; Marcus J Trunk; Jacobus Pfisterer; Andreas du Bois
Survival benefit for patients with advanced-stage transitional cell carcinomas vs. other subtypes of ovarian carcinoma after chemotherapy with platinum and paclitaxel.
Gynecologic oncology 2005;97(1):195-9.
2005: Maret Bauer; Felix Hilpert; Norbert Arnold; Jacobus Pfisterer; Walter Jonat; Hermann Kruse
Simultaneous congener-specific determination of selected organochlorine compounds and nitro musks in human whole blood samples by solid-phase extraction and capillary gas chromatography with electron capture detection.
Journal of analytical toxicology 2005;29(2):110-7.
2005: Andreas du Bois; Justine Rochon; C Lamparter; Jacobus Pfisterer
Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2005;15(2):183-91.
2005: Andreas du Bois; Justine Rochon; C Lamparter; Jacobus Pfisterer
[Impact of center characteristics on outcome in ovarian cancer in Germany].
Zentralblatt für Gynäkologie 2005;127(1):18-30.
2005: Andreas du Bois; Justine Rochon; C Lamparter; Jacobus Pfisterer
[The Quality Assurance Program of the AGO Organkommission OVAR (QS-OVAR): Pattern of Care and Reality in Germany 2001].
Zentralblatt für Gynäkologie 2005;127(1):9-17.
2005: Andreas du Bois; A Belau; Uwe Wagner; Jacobus Pfisterer; Barbara Schmalfeldt; Barbara Richter; A Staehle; Christian Jackisch; Hans-Joachim Lueck; Willibald Schroeder; Alexander Burges; Sigrid Olbricht; G Elser
A phase II study of paclitaxel, carboplatin, and gemcitabine in previously untreated patients with epithelial ovarian cancer FIGO stage IC-IV (AGO-OVAR protocol OVAR-8).
Gynecologic oncology 2005;96(2):444-51.
2005: M Quinn; E Avall-Lundqvist; Andreas du Bois; Jan B Vermorken; Mahesh Parmar; Jacobus Pfisterer; G Stuart; Tate Thigpen; JP Neijt
History, scope and methodology of the 3rd International Consensus Workshop on Ovarian Cancer 2004.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16 Suppl 8():viii5-viii6.
2005: Jan B Vermorken; E Avall-Lundqvist; Jacobus Pfisterer; M Bacon
The Gynecologic Cancer Intergroup (GCIG): history and current status.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16 Suppl 8():viii39-viii42.
2005: M Quinn; Jacobus Pfisterer; E Avall-Lundqvist; Michael A Bookman; D Bowtell; A Casado; A Cervantes; S Grenman; P Harper; Amit Oza; S Pecorelli; Eric Pujade-Lauraine; E Trimble; P Vasey; U Wagner
Integration of new or experimental treatment options and new approaches to clinical trials.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16 Suppl 8():viii30-viii35.
2004: Andreas du Bois; Jacobus Pfisterer
[First-line therapy in ovarian cancer].
Zentralblatt für Gynäkologie 2004;126(5):312-4.
2004: Eva-Katrin Riener; Norbert Arnold; Friedrich Kommoss; Stefan Lauinger; Jacobus Pfisterer
The prognostic and predictive value of immunohistochemically detected HER-2/neu overexpression in 361 patients with ovarian cancer: a multicenter study.
Gynecologic oncology 2004;95(1):89-94.
2004: Jan Bernd Weise; Steffen Maune; Tibor Görögh; Dieter Kabelitz; Norbert Arnold; Jacobus Pfisterer; Felix Hilpert; Axel Heiser
A dendritic cell based hybrid cell vaccine generated by electrofusion for immunotherapy strategies in HNSCC.
Auris, nasus, larynx 2004;31(2):149-53.
2004: Jan Bernd Weise; Felix Hilpert; Axel Heiser; Tibor Görögh; Jens Eduard Meyer; Jörg Weimer; Christoph Krüger; Andreas Rosenau; Wilm Wieckhorst; Norbert Arnold; Jacobus Pfisterer; Dieter Kabelitz; Steffen Maune
Electrofusion generates diverse DC-tumour cell hybrids for cancer immunotherapy.
Anticancer research 2004;24(2B):929-34.
2004: Jacobus Pfisterer; Andreas du Bois; Uwe Wagner; Jens Quaas; Jens-Uwe Blohmer; D Wallwiener; Felix Hilpert
Docetaxel and carboplatin as first-line chemotherapy in patients with advanced gynecological tumors. A phase I/II trial of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO-OVAR) Ovarian Cancer Study Group.
Gynecologic oncology 2004;92(3):949-56.
2004: Jacobus Pfisterer; Andreas du Bois; Felix Hilpert; U Wagner; W Meier
[Advances in the treatment of ovarian carcinoma].
Deutsche medizinische Wochenschrift (1946) 2004;129(8):379-84.
2003: Andreas du Bois; Jacobus Pfisterer; Werner Meier; Uwe Wagner
Improving first-line therapy of advanced ovarian cancer - the AGO Ovarian Cancer Study Group perspective.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2003;13 Suppl 2():169-71.
2003: Jacobus Pfisterer; Felix Hilpert; Andreas du Bois; W Meier; U Wagner
State-of-the-art first-line treatment of ovarian cancer.
Onkologie 2003;26(5):446-50.
2003: Andreas du Bois; Hans-Joachim Lück; Werner Meier; Hans-Peter Adams; Volker Möbus; Serban Costa; Thomas Bauknecht; Barbara Richter; Matthias Warm; Willibald Schröder; Sigrid Olbricht; Ulrike Nitz; Christian Jackisch; Günther Emons; Uwe Wagner; Walther Kuhn; Jacobus Pfisterer
A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.
Journal of the National Cancer Institute 2003;95(17):1320-9.
2002: Gunnar Wasner; Felix Hilpert; Jörn Schattschneider; Andreas Binder; Jacobus Pfisterer; Ralf Baron
Docetaxel-induced nail changes--a neurogenic mechanism: a case report.
Journal of neuro-oncology 2002;58(2):167-74.
2001: Andreas du Bois; Hans-Joachim Lück; Jacobus Pfisterer; Willibald Schroeder; Jens-Uwe Blohmer; Rainer Kimmig; V Moebus; Jens Quaas
Second-line carboplatin and gemcitabine in platinum sensitive ovarian cancer--a dose-finding study by the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Ovarian Cancer Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(8):1115-20.
2001: Gunnar Wasner; Felix Hilpert; Ralf Baron; Jacobus Pfisterer
Clinical picture: nail changes secondary to docetaxel.
Lancet 2001;357(9260):910.
2001: Hans-Joachim Lück; Andreas du Bois; B Weber; Jacobus Pfisterer; A Goupil; W Kuhn; J C Barats; Jens-Uwe Blohmer; M Mousseau; W Schröder; W Meier; Volker Möbus; B Richter
The integration of anthracyclines in the treatment of advanced ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2001;11 Suppl 1():34-8.
2000: Marion Kiechle; M Hinrichs; A Jacobsen; Jutta Lüttges; Jacobus Pfisterer; Friedrich Kommoss; N Arnold
Genetic imbalances in precursor lesions of endometrial cancer detected by comparative genomic hybridization.
The American journal of pathology 2000;156(6):1827-33.
2000: Andreas du Bois; Hans-Joachim Lück; Jacobus Pfisterer; W Meier; Thomas Bauknecht
[Anthracyclines in therapy of ovarian carcinoma: a systematic review of primary and 2nd-line therapy after platinum].
Zentralblatt für Gynäkologie 2000;122(5):255-67.
1999: Andreas du Bois; Hans-Joachim Lück; Thomas Bauknecht; Werner Meier; Barbara Richter; Walther Kuhn; Jens Quaas; Jacobus Pfisterer
First-line chemotherapy with epirubicin, paclitaxel, and carboplatin for advanced ovarian cancer: a phase I/II study of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(1):46-51.
1998: Friedrich Kommoss; Ulrich Karck; Heinrich Prömpeler; Jacobus Pfisterer; Charles James Kirkpatrick
Steroid receptor expression in endometria from women treated with tamoxifen.
Gynecologic oncology 1998;70(2):188-91.
1996: Norbert Arnold; L Hagele; L Walz; Werner Schempp; Jacobus Pfisterer; Thomas Bauknecht; Marion Kiechle
Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer.
Genes, chromosomes & cancer 1996;16(1):46-54.
1996: H Ikenberg; I Wiegering; Jacobus Pfisterer; M Kiechle-Schwarz; B Schmitt; Willi Sauerbrei; A Pfleiderer
Human papillomavirus DNA in tumor-free regional lymph nodes: a potential prognostic marker in cervical carcinoma.
The cancer journal from Scientific American 1996;2(1):28-34.
1996: Andreas du Bois; Friedrich Kommoss; Jacobus Pfisterer; Hans-Joachim Lück; Hans-Gerd Meerpohl
Paclitaxel-induced "recall" soft tissue ulcerations occurring at the site of previous subcutaneous administration of paclitaxel in low doses.
Gynecologic oncology 1996;60(1):94-6.
1995: Jacobus Pfisterer; Friedrich Kommoss; Willi Sauerbrei; D Menzel; Marion Kiechle; E Giese; M Hilgarth; A Pfleiderer
DNA flow cytometry in node-positive breast cancer. Prognostic value and correlation with morphologic and clinical factors.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 1995;17(6):406-12.
1995: Bonnie L King; M L Carcangiu; Darryl L Carter; Marion Kiechle; Jacobus Pfisterer; A Pfleiderer; Barry M Kacinski
Microsatellite instability in ovarian neoplasms.
British journal of cancer 1995;72(2):376-82.
1995: Jacobus Pfisterer; Friedrich Kommoss; Willi Sauerbrei; I Rendl; Marion Kiechle; W Kleine; A Pfleiderer
Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma.
Gynecologic oncology 1995;58(2):149-56.
1994: Jacobus Pfisterer; Friedrich Kommoss; Willi Sauerbrei; H Renz; Andreas du Bois; M Kiechle-Schwarz; A Pfleiderer
Cellular DNA content and survival in advanced ovarian carcinoma.
Cancer 1994;74(9):2509-15.
1994: Friedrich Kommoss; J Wölfle; Thomas Bauknecht; Jacobus Pfisterer; M Kiechle-Schwarz; A Pfleiderer; Willi Sauerbrei; R Kiehl; Barry M Kacinski
Co-expression of M-CSF transcripts and protein, FMS (M-CSF receptor) transcripts and protein, and steroid receptor content in adenocarcinomas of the ovary.
The Journal of pathology 1994;174(2):111-9.
1994: Peter Dall; Jacobus Pfisterer; Andreas du Bois; C Wilhelm; A Pfleiderer
Therapeutic strategies in cervical pregnancy.
European journal of obstetrics, gynecology, and reproductive biology 1994;56(3):195-200.
1994: Friedrich Kommoss; Jacobus Pfisterer; T Idris; E Giese; Willi Sauerbrei; W Schäfer; M Thome; A Pfleiderer
Steroid receptors in carcinoma of the breast. Results of immunocytochemical and biochemical determination and their effects on short-term prognosis.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 1994;16(3):203-10.
1994: H Ikenberg; C Spitz; B Schmitt; Jacobus Pfisterer; U Aisslinger; A Pfleiderer
Human papillomavirus DNA in locally recurrent cervical cancer.
Gynecologic oncology 1994;52(3):332-6.
1994: Georg Schwarzkopf; Jacobus Pfisterer
[Metastasizing gastrinoma and tuberous sclerosis complex. Association or coincidence?].
Zentralblatt für Pathologie 1994;139(6):477-81.
1994: Andreas du Bois; Hans-Gerd Meerpohl; Helmut Madjar; D Spinner; Peter Dall; Jacobus Pfisterer; Thomas Bauknecht
Phase II study of pirarubicin combined with cisplatin in recurrent ovarian cancer.
Journal of cancer research and clinical oncology 1994;120(3):173-8.
1993: H Ikenberg; A Göppinger; M Hilgarth; Jacobus Pfisterer; U Müller; H G Hillemanns; A Pfleiderer
Human papillomavirus, type 16, DNA in multicentric anogenital neoplasia associated with idiopathic panmyelopathy. A case report.
The Journal of reproductive medicine 1993;38(10):820-2.
1993: Friedrich Kommoss; G DeGregorio; B Strittmatter; Jacobus Pfisterer; U Karck; Hans-Peter Zahradnik; M Breckwoldt
[Obstetric complications, incidence and indications of cesarean section in uterus myomatosus].
Geburtshilfe und Frauenheilkunde 1993;53(8):564-7.
1992: Friedrich Kommoss; Jacobus Pfisterer; M Thome; W Schäfer; Willi Sauerbrei; A Pfleiderer
Steroid receptors in ovarian carcinoma: immunohistochemical determination may lead to new aspects.
Gynecologic oncology 1992;47(3):317-22.
1991: Jacobus Pfisterer; H M Runge; Friedrich Kommoss; E W Herbst; H G Hillemanns
[Primary pulmonary hypertension and pregnancy].
Geburtshilfe und Frauenheilkunde 1991;51(3):236-8.
1989: Jacobus Pfisterer; S Schön; H Blum; H H Peter; E W Herbst
[An unusual slow course of systemic vasculitis with multiorgan involvement].
Immunität und Infektion 1989;17(2):57-9.
1989: S Schön; Jacobus Pfisterer; H Blum; H Wollschläger; H H Peter; E W Herbst
[A 35-year-old patient with necrotizing exanthema, restrictive cardiomyopathy, liver cirrhosis and acute psychosis].
Medizinische Klinik (Munich, Germany : 1983) 1989;84(3):139-43.